CMS Holds 300 Validated Medicare Rx Formularies As Submission Deadline Nears
This article was originally published in The Pink Sheet Daily
The original deadline for Part D formularies was extended until April 22 for the benefit of potential sponsors, not because the agency is falling behind schedule, CMS' Tudor says. Caremark and PacifiCare execs question why the deadline was moved.
You may also be interested in...
The Centers for Medicare & Medicaid Services is extending the deadline for submitting Medicare Part D drug plan formularies to the agency
Seniors will not be overwhelmed by a high number of plan choices, the agency administrator maintains. CMS has received a large volume of Part D applications, but not all look “complete and serious,” McClellan indicates.
FDA asks Endo to disseminate “corrective messages” to doctors who received the violative promotional materials, which the agency says omit risk information and contain unsubstantiated effectiveness claims.